DE60329014D1 - Hydroxypyridinone zur lokalen behandlung von hautmikrozirulationsstörungen - Google Patents

Hydroxypyridinone zur lokalen behandlung von hautmikrozirulationsstörungen

Info

Publication number
DE60329014D1
DE60329014D1 DE60329014T DE60329014T DE60329014D1 DE 60329014 D1 DE60329014 D1 DE 60329014D1 DE 60329014 T DE60329014 T DE 60329014T DE 60329014 T DE60329014 T DE 60329014T DE 60329014 D1 DE60329014 D1 DE 60329014D1
Authority
DE
Germany
Prior art keywords
skin
microcirulate
hydroxypyridinone
disorder
local treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60329014T
Other languages
English (en)
Inventor
Carlo Ghisalberti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Relivia SRL
Original Assignee
Relivia SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Relivia SRL filed Critical Relivia SRL
Application granted granted Critical
Publication of DE60329014D1 publication Critical patent/DE60329014D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
DE60329014T 2002-11-19 2003-11-19 Hydroxypyridinone zur lokalen behandlung von hautmikrozirulationsstörungen Expired - Lifetime DE60329014D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002447A ITMI20022447A1 (it) 2002-11-19 2002-11-19 Uso di piridinoni nel trattamento della purpura capillare ed affezioni cutanee correlate.
PCT/IB2003/005222 WO2004045609A2 (en) 2002-11-19 2003-11-19 Hydroxypyridinones for the local treatment of skin microcirculatory disorders

Publications (1)

Publication Number Publication Date
DE60329014D1 true DE60329014D1 (de) 2009-10-08

Family

ID=32321426

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60329014T Expired - Lifetime DE60329014D1 (de) 2002-11-19 2003-11-19 Hydroxypyridinone zur lokalen behandlung von hautmikrozirulationsstörungen

Country Status (8)

Country Link
US (2) US20060135448A1 (de)
EP (1) EP1567156B1 (de)
AT (1) ATE440601T1 (de)
AU (1) AU2003280071A1 (de)
DE (1) DE60329014D1 (de)
ES (1) ES2332452T3 (de)
IT (1) ITMI20022447A1 (de)
WO (1) WO2004045609A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI448285B (zh) * 2006-07-13 2014-08-11 Los Angeles Biomed Res Inst 用以治療白黴菌症(mucormycosis)及其他真菌類疾病之組合物及方法
MA33199B1 (fr) 2009-03-19 2012-04-02 Los Angeles Biomed Res Inst Compositions de vaccin et procédés pour le traitement de la mucormycose et d'autres maladies fongiques
DE102009027483A1 (de) * 2009-07-06 2011-01-13 Henkel Ag & Co. Kgaa Deodorantien und Antitranspirantien mit haarwuchsminimierender oder -inhibierender Wirkung
CA2779147A1 (en) * 2009-10-28 2011-05-12 Eugene B. Guthery Rosacea topical skin treatment method and formulation
EP3195854A1 (de) 2016-01-22 2017-07-26 Tomorrowlabs GmbH Kosmetische behandlung gesunder haut, insbesondere gealterter haut
EP3852711A4 (de) * 2018-09-20 2022-06-08 Tautona Group IP Holding Company, L.L.C. Eisenchelatierende verbindungen zur behandlung von ästhetischen hautstörungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001508755A (ja) * 1994-04-08 2001-07-03 ザ、プロクター、エンド、ギャンブル、カンパニー 哺乳動物でラジカルダメージを減少させるために鉄キレート化合物を用いる方法
DE19639817A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen
US6472432B1 (en) * 1997-11-17 2002-10-29 Nicholas V. Perricone Treatment of rosacea using lipoic acid
US6630163B1 (en) * 1999-04-22 2003-10-07 Howard Murad Method of treating dermatological disorders with fruit extracts
IT1316059B1 (it) * 1999-09-09 2003-03-28 Carlo Ghisalberti Depigmentanti cutanei.
CA2480225A1 (en) * 2002-04-04 2003-10-16 Eugene H. Gans Methods for treating rosacea with pyridones

Also Published As

Publication number Publication date
ATE440601T1 (de) 2009-09-15
WO2004045609A2 (en) 2004-06-03
AU2003280071A1 (en) 2004-06-15
ES2332452T3 (es) 2010-02-05
EP1567156A2 (de) 2005-08-31
ITMI20022447A1 (it) 2004-05-20
US20060135448A1 (en) 2006-06-22
WO2004045609A3 (en) 2004-09-16
EP1567156B1 (de) 2009-08-26
US20120077852A1 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
EA200601776A1 (ru) Метадоновые композиции местного действия и способы их применения
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
BRPI0510094A (pt) uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
MX2007002689A (es) 7-azaindoles y su uso como agonistas de ppar.
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
EA200870088A1 (ru) Применение бензоконденсированных гетероциклических сульфамидных производных для понижения уровней липидов и глюкозы в крови
MXPA05008438A (es) Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6.
MXPA06012143A (es) Arilsulfonamidas y usos relacionados con las mismas.
ATE447403T1 (de) Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
EE200400005A (et) Tablett, mis sisaldab vähemalt kahte eristatavat segmenti ning selle kasutamine
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
DE60329014D1 (de) Hydroxypyridinone zur lokalen behandlung von hautmikrozirulationsstörungen
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
NO20073104L (no) Anvendelse av en 5-HT6 agonist for behandling og forebygging av neurodegenerative forstyrrelser
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
EA200500865A1 (ru) Синергетическая комбинация, включающая рофлумиласт и r,r-формотерол

Legal Events

Date Code Title Description
8364 No opposition during term of opposition